状细胞癌的瘤肌瘤:一个复杂的环境,燃料癌症的进展
Alexandra Buruiană1, Bogdan-Alexandru Gheban2,3, Ioana-Andreea Gheban-Roșca4
1Department of Pathology, Iuliu Haţieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Cancers
|May 11, 2024
概括
皮肤状细胞癌 (cSCC) 的瘤微环境 (TME) 涉及复杂的细胞和基质相互作用,驱动癌症的进展. 针对这些TME组件,为cSCC治疗提供了有前途的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 癌症生物学 癌症生物学
背景情况:
- 瘤微环境 (TME) 是瘤进展,转移和治疗反应的关键决定因素.
- 皮肤状细胞癌 (cSCC) 是一种常见的皮肤癌,其中TME起着重要作用.
研究的目的:
- 审查cSCC TME的关键细胞和细胞外矩阵 (ECM) 组件.
- 探索TME变化如何促进cSCC进展,转移和耐药性.
- 讨论针对cSCC TME的新兴治疗策略.
主要方法:
- 这是一篇叙事性综述,综合了关于cSCC瘤层的现有文献.
- 检查了ECM的关键组成部分 (纤维素,酸,拉米林,蛋白质糖,原体) 和细胞参与者 (CAF,MSC,内皮细胞,免疫细胞).
- 讨论了针对TME相互作用的治疗方法.
主要成果:
- 在cSCC ECM组成的变化,包括纤维素和原的变化,促进癌症的进展和转移.
- 细胞透的cSCC TME,包括CAFs,MSCs和免疫细胞,显著影响瘤发育和血管生成.
- TME是一个可行的治疗目标,免疫疗法和CAF破坏等策略显示出潜力.
结论:
- 了解cSCC TME内部复杂的交叉声是开发有效治疗的必要条件.
- 针对特定的TME组件,如CAF或ECM,是推进cSCC治疗的有希望的途径.
- 对TME动态的进一步研究可能会为cSCC带来新的治疗策略.
更多相关视频
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:18Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K